|
On December 2, 2022, President Biden signed the Medical Marijuana and Cannabidiol Research Expansion Act into law. This law-which was supported by the Foundation-will make it significantly easier to conduct medical research on cannabis in the United States. Importantly for people with epilepsy, the law also clarifies that health care providers may discuss the benefits and risks of cannabis as a medical treatment with their patients without violating the Controlled Substances Act. Many p had been reluctant to discuss cannabis and CBD use with their patients for fear of legal repercussions. We hope that this change will result in improved communications between people with epilepsy and their Ciao Health formula care providers, resulting in improved treatment and outcomes. As of November 2022, 48 states and the District of Columbia have legalized either the recreational or medical use of cannabis, or allow access to CBD, on the local level. Under federal law, cannabis is currently a Schedule I controlled substance, and illegal to use, buy, sell, or possess. |
|